OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
A Clinical Outcome of the Anti-PD-1 Therapy of Melanoma in Polish Patients Is Mediated by Population-Specific Gut Microbiome Composition
Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik‐Schmidt, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5369-5369
Open Access | Times Cited: 12
Bernadeta Pietrzak, Katarzyna Tomela, Agnieszka Olejnik‐Schmidt, et al.
Cancers (2022) Vol. 14, Iss. 21, pp. 5369-5369
Open Access | Times Cited: 12
Showing 12 citing articles:
Longitudinal gut microbiome changes in immune checkpoint blockade-treated advanced melanoma
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 785-796
Open Access | Times Cited: 50
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Nature Medicine (2024) Vol. 30, Iss. 3, pp. 785-796
Open Access | Times Cited: 50
Role of the Microbiome and Diet for Response to Cancer Checkpoint Immunotherapy: A Narrative Review of Clinical Trials
Lone Gamrath, Tina H. Pedersen, Mecker G. Möller, et al.
Current Oncology Reports (2025)
Open Access | Times Cited: 3
Lone Gamrath, Tina H. Pedersen, Mecker G. Möller, et al.
Current Oncology Reports (2025)
Open Access | Times Cited: 3
Microbiome bacterial influencers of host immunity and response to immunotherapy
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 14
Yeganeh Yousefi, Kelly J. Baines, Saman Maleki Vareki
Cell Reports Medicine (2024) Vol. 5, Iss. 4, pp. 101487-101487
Open Access | Times Cited: 14
Gut microbiota and metabolites signatures of clinical response in anti-PD-1/PD-L1 based immunotherapy of biliary tract cancer
Chengpei Zhu, Yunchao Wang, Ruijuan Zhu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Chengpei Zhu, Yunchao Wang, Ruijuan Zhu, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 13
Role of gut microbiota in regulating immune checkpoint inhibitor therapy for glioblastoma
Hao Zhang, Ying Hong, Tingting Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Hao Zhang, Ying Hong, Tingting Wu, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 10
Unveiling the Power of Gut Microbiome in Predicting Neoadjuvant Immunochemotherapy Responses in Esophageal Squamous Cell Carcinoma
Le Liu, Li‐Ping Liang, Yingxia Luo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 4
Le Liu, Li‐Ping Liang, Yingxia Luo, et al.
Research (2024) Vol. 7
Open Access | Times Cited: 4
Microbiota-centered interventions to boost immune checkpoint blockade therapies
Andrew A. Almonte, Simon Thomas, Laurence Zitvogel
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 7
Closed Access
Andrew A. Almonte, Simon Thomas, Laurence Zitvogel
The Journal of Experimental Medicine (2025) Vol. 222, Iss. 7
Closed Access
Gut microbiome metabolites, molecular mimicry, and species-level variation drive long-term efficacy and adverse event outcomes in lung cancer survivors
Xinyu Liu, Bo Lü, Hao Tang, et al.
EBioMedicine (2024) Vol. 109, pp. 105427-105427
Closed Access | Times Cited: 3
Xinyu Liu, Bo Lü, Hao Tang, et al.
EBioMedicine (2024) Vol. 109, pp. 105427-105427
Closed Access | Times Cited: 3
Zanthoxylum bungeanum seed oil inhibits tumorigenesis of human melanoma A375 by regulating CDC25A/CyclinB1/CDK1 signaling pathways in vitro and in vivo
Wanting Wang, Wenwen Pang, Suying Yan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Wanting Wang, Wenwen Pang, Suying Yan, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 3
Immune-reactive tumor organoids system to determine the effects of microbial metabolites on cancer immunity and immunotherapies
Azza M. El-Derby, Cecilia R. Schaaf, Ethan Shelkey, et al.
Frontiers in Microbiomes (2024) Vol. 3
Open Access
Azza M. El-Derby, Cecilia R. Schaaf, Ethan Shelkey, et al.
Frontiers in Microbiomes (2024) Vol. 3
Open Access
A two-step, two-sample Mendelian randomization analysis investigating the interplay between gut microbiota, immune cells, and melanoma skin cancer
Jiaqi Lou, Ziyi Xiang, Xiaoyu Zhu, et al.
Medicine (2024) Vol. 103, Iss. 45, pp. e40432-e40432
Open Access
Jiaqi Lou, Ziyi Xiang, Xiaoyu Zhu, et al.
Medicine (2024) Vol. 103, Iss. 45, pp. e40432-e40432
Open Access
Circadian lifestyle determinants of immune checkpoint inhibitor efficacy
Bethan R. Hughes, Sadiq Shanaz, Seline Ismail-Sutton, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Bethan R. Hughes, Sadiq Shanaz, Seline Ismail-Sutton, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 1
Longitudinal gut microbiome changes in immune checkpoint blockade in advanced melanoma
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Research Square (Research Square) (2023)
Open Access
Johannes R. Björk, Laura A. Bolte, Andrew Maltez Thomas, et al.
Research Square (Research Square) (2023)
Open Access
